BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20210688)

  • 1. Topical n-docosanol for management of recurrent herpes labialis.
    Treister NS; Woo SB
    Expert Opin Pharmacother; 2010 Apr; 11(5):853-60. PubMed ID: 20210688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
    Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosanol: a topical antiviral for herpes labialis.
    Leung DT; Sacks SL
    Expert Opin Pharmacother; 2004 Dec; 5(12):2567-71. PubMed ID: 15571473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosanol cream (Abreva) for recurrent herpes labialis.
    Med Lett Drugs Ther; 2000 Nov; 42(1092):108. PubMed ID: 11077469
    [No Abstract]   [Full Text] [Related]  

  • 6. Management and prevention of recurrent herpes labialis in immunocompetent patients.
    Gilbert SC
    Herpes; 2007 Dec; 14(3):56-61. PubMed ID: 18371287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
    Habbema L; De Boulle K; Roders GA; Katz DH
    Acta Derm Venereol; 1996 Nov; 76(6):479-81. PubMed ID: 8982417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical management measures for patients with recurrent herpes labialis.
    St Pierre SA; Bartlett BL; Schlosser BJ
    Skin Therapy Lett; 2009; 14(8):1-3. PubMed ID: 20054504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
    McKeough MB; Spruance SL
    Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of recurrent oral herpes simplex infections.
    Woo SB; Challacombe SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S12.e1-18. PubMed ID: 17379150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of docosanol.
    Sacks SL
    J Am Acad Dermatol; 2003 Sep; 49(3):558-9. PubMed ID: 12963936
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
    Arduino PG; Porter SR
    Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Docosanol (Erazaban), dermal use].
    J Pharm Belg; 2011 Jun; (2):53-4. PubMed ID: 21823443
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
    Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
    J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of herpes simplex labialis.
    Spruance SL; Kriesel JD
    Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.
    Harmenberg J; Oberg B; Spruance S
    Acta Derm Venereol; 2010 Mar; 90(2):122-30. PubMed ID: 20169294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-docosanol (Abreva) for herpes labialis: problems and questions.
    Spruance SL
    J Am Acad Dermatol; 2002 Sep; 47(3):457-8. PubMed ID: 12196766
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xereseâ„¢) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.